Skip to main content

Co-Diagnostics, Inc.

CODX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001692415

No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.

Holders of 5% or more of CODX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Co-Diagnostics, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Co-Diagnostics, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

2 Schedule 13D and 13G filings on Co-Diagnostics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CODX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 19, 20254:05 PM ETOrca Capital AG13G/A4.60%2.19M shares−5.30 ppfrom 9.90%Below 5%Sep 18, 2025SEC
Sep 18, 20254:05 PM ETOrca Capital AG13G9.90%4.81M sharesNewSep 17, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Co-Diagnostics, Inc. shares.

No Form 144 notices for Co-Diagnostics, Inc. are on file.